Dottorato in Medicina Molecolare

S Rolla*, F Ria*, S Occhipinti, G Di Sante, M Iezzi, M Spadaro, C Nicolo, E Ambrosino, I Fiore Merighi, P Musiani, G Forni and F Cavallo. Erbb-2 DNA vaccine combined with regulatory T cell deletion enhances antibody response and reveals latent low-avidity T cells: Potential and limit of its therapeutic efficacy. The Journal of Immunology, 2010.

S Occhipinti, C Dianzani, A Chiocchetti, E Boggio, N Clemente, CL Gigliotti, MF Soluri, R Minelli, R Fantozzi, J Yagi, JM Rojo, D Sblattero, M Giovarelli and U Dianzani. Triggering of B7h by the inducible costimulator modulates maturation and migration of monocyte-derived dendritic cells. The Journal of Immunology, 2013

R Minelli, S Occhipinti, C L Gigliotti, G Barrera, P Gasco, L Conti, A Chiocchetti, G P Zara, R Fantozzi, M Giovarelli, U Dianzani, C Dianzani. Cholesteryl butyrate solid lipid nanoparticles inhibit the proliferation of cancer cells in vitro and in vivo models. British Journal of Pharmacology, 2013

 

R Cojoca, S Rolla, S Occhipinti, H Pinto, G Forni, and F Cavallo. Silencing IL-10 gene with intra-mammary siRNA enables DNA vaccination to inhibit established ErbB2 carcinomas. EACR, Lion, July 5-8, 2008

S Rolla, S Occhipinti, R Cojoca, M Spadaro, R Penitente, F Ria, and F Cavallo. Targeting CD4+ CD25+ FOXP3+ Treg cells abrogates established mechanisms of immune tolerance, reshuffles the T cell repertoire and  results in effective anti-tumor immunity. EACR, Lion, July 5-8, 2008

S Rolla, F Ria, S Occhipinti, G Di Sante, M Iezzi, M Spadaro, C Nicolò, E Ambrosino, I Fiore Merighi, P Musiani, G Forni, and F Cavallo. Erbb2 DNA Vaccine Combined with Regulatory T Cell Deletion Enhances Antibody Response and Reveals Latent Low-Avidity T Cells: Potential and Limits of Its Therapeutic Efficacy. Keystone Symposia on Molecular and Cellular Biology, Keystone, February 7-12 2010

S Occhipinti, L Sponton, C Caorsi, A Amici, C Marchini, G Forni, A Novarino, M Donadio, L Ciuffreda, A Sapino, G Inghirami, F Novelli and M Giovarelli. Dendritic cells transfected with DNA  encoding ErbB-2 rat/human chimeric plasmid are able to activate in vitro a specific T cell response in ErbB-2+ cancer patients. 9th CIMT Annual meeting, Mainz, 25-27 may 2011.

I Miceli, E Favaro, C Caorsi, S Occhipinti, G Grassi, V Inglese, E Camussi, M Giovarelli, P Cavallo Perin, G Camussi, MM Zanone. Human mesenchymal stem cells modulate dendritic cells presentation of islet antigen GAD65 in type 1 diabetes. EASD, Lisboa 12-16 september 2011

S Occhipinti, L Sponton, C Caorsi, A Amici, C Marchini, E Quaglino, A Novarino, M Donadio, A Sapino, F Novelli and M Giovarelli. Dendritic cells transfected with ErbB-2 rat/human hybrid plasmid elicit an effective T cells response in ErbB-2+ cancer patients. 1st Gene Vaccination in Cancer, Ascoli Piceno, 15-17 september 2011.

S Occhipinti, L Sponton, C Caorsi, A Amici, C Marchini, E Quaglino, A Novarino, M Donadio, L Ciuffreda, A Sapino, G Inghirami, F Novelli and M Giovarelli. Effective T cells response can be elicide in ErbB-2+ cancer patients by ErbB-2 rat/human hybrid plasmid transfection of dendritic cells. 2011 Joint annual meeting, SIICA-DGfI, Riccione, 28 september-1 october 2011

L Sponton, S Occhipinti, F Novelli, M Giovarelli. High Mobility Group Box 1 (hmgb1) Expands CD4+CD25+Foxp3+ T Cells and Increases the Expression of CD39. 9th Joint Meeting of the ICS/ISICR, Florence, 9-12 october 2011

S Occhipinti, L Sponton, C Caorsi, A Amici, C Marchini, E Quaglino, A Novarino, M Donadio, L Ciuffreda, A Sapino, F Novelli and M Giovarelli. Dendritic cells transfected with ErbB-2 rat/human hybrid plasmid elicit an effective T cells response in ErbB-2+ cancer patients. 25th SITC Annual Meeting, North Bethesda, Maryland, US, 1-6 november 2011.

S Occhipinti, L Sponton, C Caorsi, A Amici, C Marchini, E Quaglino, A Novarino, M Donadio, L Ciuffreda, A Sapino, F Novelli and M Giovarelli. DNA vaccines coding for chimeric human/rat HER2 as innovative immunotherapeutic tools for treatment of HER2+ cancer patients. Riunione Scientifica Scuola Dianzani, Sassari, 18-19 novembre 2011. Oral talk selected.

S Occhipinti, L Sponton, A Amici, C Marchini, E Quaglino, A Novarino, M Donadio, L Ciuffreda, A Sapino, F Novelli and M Giovarelli. ERBB2 rat/human hybrid vaccine eludes self-antigen tolerance and elicits an effective T cells response in ERBB2+ cancer patients. FOCIS, Vancouver Canada, 20-23 june 2012

S Occhipinti, L Sponton, A Amici, C Marchini, E Quaglino, A Novarino, M Donadio, L Ciuffreda, A Sapino, F Novelli and M Giovarelli. Neutralization of IL-10 and TGFβ1 rescues T cells from tolerogenic mechanisms induced by HER2 vaccine in cancer patients. ECI, Glasgow, Scotland, 5-8 september 2012

E Boggio, S Occhipinti, C Dianzani, N Clemente, CL Gigliotti, R Minelli, M Giovarelli, A Chiocchetti, U. Dianzani. Triggering of B7h by the inducible costimulator modulates maturation and migration of monocyte-derived dendritic cells. ECI, Glasgow, Scotland, 5-8 september 2012

S Occhipinti, L Sponton, A Amici, C Marchini, E Quaglino, A Novarino, M Donadio, L Ciuffreda, A Sapino, F Novelli and M Giovarelli. Self and xenogeneic variants of HER2 differently affect t cells plasticity: considerations for designing tumor vaccines. 54° Congresso Nazionale SIC, Bologna, Italy, 1-4 ottobre 2012. Oral talk selected.

R Minelli, R Cavalli, S Occhipinti, L Gigliotti, R Fantozzi, M Giovarelli, U Dianzani and C Dianzani. Antitumor effect of nanosponge-encapsulated camptothecin in human prostate tumors. 1° NEMB Venice workshop on "cancer nanotechnology“, Venice, Italy, 11-12 Ottobre 2012

 

 

 

14 marzo 2008: Workshop on gene expression in Her-2/neu mouse and human tumors: Mining a knowledge diamond. Torino, Italia

15-16 novembre 2008: Workshop Vaccines in the management of cancer: Where we are heading?. Torino, Italia

25-27 maggio 2011: 9^th CIMT Annual meeting, Mainz, Germania (poster)

15-17 settembre 2011: 1^st Gene Vaccination in Cancer, Ascoli Piceno, Italia (poster)

28 settembre-1 ottobre 2011: 2011 Joint annual meeting, SIICA-DGfI, Riccione, Italia (poster)

1-6 novembre 2011: SITC 26th Annual Meeting, North Bethesda, Maryland (US). (poster)

18-19 novembre 2011: Riunione Scientifica Scuola Dianzani, Sassari, Italia (presentazione orale)

7 giugno 2012: Cancer-day: from metabolism to immunotherapy, Torino, Italia

20-23 giugno 2012: FOCIS, Vancouver, Canada (poster)

5-8 settembre 2012: ECI, Glasgow, Scozia (poster)

1-4 ottobre 2012: 54° Congresso Nazionale SIC, Bologna (selezionato per presentazione orale)

12-13 novembre 2012: Terza Conferenza Nazionale sulla Ricerca Sanitaria, Cernobbio, Italia

- 16 marzo 2011 Seminario Roberto S. Accolla, Giovanna Tosi “Intrinsic and adaptive immunity: the dual function CIITA as viral restriction factor and as inducer of specific immunity against tumors”.

- 21 marzo 2011 Seminario Federico Garrido “The escape of cancer from immune surveillance: MHC expression and tumor rejection”.

- 10-17-24-31 maggio 2011, 7-14 giugno 2011 Corso Prof. Guido Forni “Corso Monografico sull'Immunologia dei Tumori”.

- 29 maggio 2011 “The Biology of Cancer Oncogene and Microenviroment” Fondazione Piemontese per la Ricerca sul Cancro –ONLUS.

- 21 giugno 2011 Workshop “Learn more about primary cells, cell culture reagents and mycoplasma prevention” organizzato da PB Internetional.

- 19 settembre 2011 D-Day, Scuola di Dottorato in Scienze della Vita e della Salute

- 19 ottobre 2011 Seminario  Mariano Barbacid “Mouse Models of Cancer: A Genetic Tool to Validate Therapeutic Targets”.

- 5 dicembre 2011 Seminario Julie Gehl “Optimising gene electrotransfer to skin and muscle clinical exprerience with electroporation based drug and gene delivery”.

- 14 dicembre 2011 VI Giornata del Dottorato di Immunologia e Biologia Cellulare.

- 11 gennaio 2012 Seminario Pier Paolo Di Fiore "Endocytosis, Stem cells and Cancer".

- 19 gennaio 2012 Seminario Ario De Marco "Biomedical application of the recombinant antibodies technology".

- 25 gennaio 2012 Seminario Pier Giuseppe Pelicci "Regulation of Self-renewal in Cancer stem cells".

- 31 gennaio 2012 Seminario Giuseppe Maruccio "Multipurpose biochips toward on-chip medicine".

- 27-28 febbraio 2012 Corso Prof. Paolo Provero "Corso di biostatistica".

- 27 marzo 2012 Seminario Ethan M Shevach "Foxp3+ T Regulatory Cells: What do they really do?".